Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2008-05-20
2008-05-20
Mosher, Mary E. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C424S001170, C435S235100, C435S007230, C530S326000, C530S324000, C530S333000
Reexamination Certificate
active
10466835
ABSTRACT:
The present invention relates to a family of peptides exhibiting high affinity and specificity for the viral protein gp120, to methods for producing these peptides, and to the use of these peptides.
REFERENCES:
patent: 4684622 (1987-08-01), Huffman et al.
patent: 4721704 (1988-01-01), Chang et al.
Vita, et al. “Rational Engineering of a miniprotein that reproduces the core of the CD4 site interacting with the HIV-1 envelope glycoprotein” PNAS Nov. 9, 1999 vol. 96(23):13091-13096.
Vita, et al. Peptides 2000, Proceedings of the European Peptide Symposium, 26th, Montpellier, France, Sep. 10-15, 2000 (2001), Meeting Date 2000, 443-444 . Editor(s): Martinez, Jean; Fehrentz, Jean-Alain. Editions EDK: Paris, Fr.
Hruby VJ and Bonner GG, “Design of Novel Synthetic Peptides Including Cyclic Conformationally and Topographically Constrained Analogs” in Methods in Molecular Biology: 35, Peptide Synthesis Protocols, Ed.: Pennington MW and Dunn BM, Humana Press: Totowa, NJ, (1994).
L. Martin et al.: “Engineering novel bioactive mini-proteins on natural scaffolds” Tetrahedron, vol. 56, No. 48, pp. 9451-9460 Nov. 24, 2000.
Claudio Vita et al.: “Rational engineering of a miniprotein that reporduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein” Proceedings of the National Academy of Sciences of the United States, vol. 96, No. 23, pp. 13091-13096, Nov. 9, 1999.
P.D. Kwong et al. Nature, vol. 393, pp. 648-659 1998.
R.W. Sweet et al. Curr. Opin. Biotechnol., vol. 2, pp. 622-633, 1991.
S.E. Ryu et al. Structure, vol. 2, pp. 59-74, 1994.
Y. Feng et al. Science, vol. 272, pp. 872-877, 1996.
H. Choe et al. Cell, vol. 85, pp. 1135-1148, 1996.
T. Dragic et al. Nature, vol. 381, pp. 667-673, 1996.
G. Alkhatib et al. Science, vol. 272, pp. 1955-1958, 1996.
L. Wu et al. Nature, vol. 384, pp. 179-183, 1996.
A. Trkola et al. Nature, vol. 384, pp. 184-187, 1996.
M. Thali et al. J. Virol., vol. 67, pp. 3978-3988, 1993.
R. Wyatt et al. J. Virol., vol. 69, pp. 5723-2733, 1993.
J. Moore et al. J. Virol., vol. 70, pp. 1863-1872, 1996.
S. Chen et al. Proc. Natl. Acad. Sci., USA, vol. 89, pp. 5872-5876, 1992.
X. Zhang et al. Nature Biotechnol., vol. 15, pp. 150-154, 1997.
J.P. Moore et al. Perspect. Drug Disc. Design, vol. 1, pp. 235-250, 1993.
G.P. Allaway et al. Aids Res Hum Retroviruses, vol. 11, pp. 533-539, 1995.
M. Ono et al. Nat. Biotechnol., vol. 15, pp. 343-348 1997.
J.O. Ojwang et al Antimicrob. Agents Chemother., vol. 39, pp. 2426-2435, 1995.
S. Rusconi et al. Antimicrob. Agents Chemother., vol. 40, pp. 234-236, 1996.
E. De Clercq Pure Appl. Chem., vol. 70, pp. 567-577, 1988.
N. Yahi et al. Proc. Natl. Acad. Sci. USA, vol. 92, pp. 4867-4871, 1995.
E. De Clercq et al. Antimicrob. Agents Chemother., vol. 38, pp. 668-674, 1994.
O.M.Z. Howard et al. J. Med. Chem., 41, pp. 2184-2193, 1998.
H. Tamamura et al. Biophys. Res. Commun., vol. 205, pp. 1729-1735, 1994.
H. Tamamura et al. Bioorg. Med. Chem. Lett., vol. 10, pp. 2633-2637, 2000.
M. Baba et al. Proc. Natl. Acad. Sci. USA, vol. 96, pp. 5698-5703, 1999.
C. Wild et al. Proc. Natl. Acad. Sci. USA, vol. 91, pp. 12676-12680, 1994.
L.T. Rimsky et al. J. Virol., vol. 72, pp. 986-993, 1998.
T.W. Chun et al. Proc. Natl. Acad. Sci. USA, vol. 96, pp. 10958-10961, 1998.
R.A. Lacasse et al. Science, vol. 283, pp. 357-362, 1999.
A. Devico et al. Virology, vol. 218, pp. 258-263, 1996.
TR Fouts et al. J. Virol., vol. 74, pp. 11427-11436, 2000.
J.L. Rossio et al. J. Virol., vol. 72, pp. 7992-8001, 1998.
S. Lee et al. J. Virol., vol. 71, pp. 6037-6043, 1997.
H. Wu et al. Proc. Natl. Acad. Sci. USA, vol. 93, pp. 15030-15035, 1996.
J.B. McMahon et al. J. Biomol. Screen, vol. 5, pp. 169-176, 2000.
J.R. Sportsman et al. Drug Discov Today, vol. 1, pp. 27-32, 2000.
C. Pernelle et al. Biochemistry, vol. 32, No. 43, pp. 11682-11687, 1993.
G. Mathis Clin. Chem., vol. 39, No. 9, pp. 1953-1959, 1993.
Martin Loic
Roumestand Christian
Veas Francisco
Vita Claudio
Commissariat a l''Energie Atomique
Mosher Mary E.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Snyder Stuart W.
LandOfFree
Peptides having affinity for the gp120 viral protein and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides having affinity for the gp120 viral protein and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides having affinity for the gp120 viral protein and use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3950305